Search
for
Sort by
Research 181–210 of 647
- Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy
- Endocrine-skin interactions
- Tumor Mapping in 2 Large Multigenerational Families With CYLD Mutations
- Acquired scalp alopecia. Part I: A review
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
- Studying the genetic predisposing factors in the pathogenesis of acne vulgaris
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Cutaneous manifestations of anabolic-androgenic steroid use in athletes
- Platelet‐rich plasma, a powerful tool in dermatology
- Lymphocytic mediated alopecia: histological classification by pattern analysis
- Changes in dermatological complaints among healthcare professionals during the COVID-19 outbreak in Turkey
- Hidradenitis Suppurativa
- Analysis of hidradenitis suppurativa–linked mutations in four genes and the effects of PSEN1-P242LfsX11 on cytokine and chemokine expression in macrophages
- Hormone therapy in acne
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- The dermatological consequences of obesity
- Is Propionibacterium acnes associated with hair casts and alopecia?
- Topical use of systemic drugs in dermatology: A comprehensive review
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Ethnic Hair Disorders
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Nanocarrier Systems for Transdermal Drug Delivery
- Cicatricial (scarring) alopecia
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Drug eruptions in dermatology
- Carboxytherapy in Aesthetic Medicine
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Psychotropic Medications and the Skin
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)